We are live on ! Find out more
IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
+26.96%
1 Year Est. Return
+17.25%
3 Year Est. Return
+11.14%
5 Year Est. Return
+79.35%
10 Year Est. Return
–
AUM
$271M
AUM Growth
+$110M
Cap. Flow
+$20.2M
Cap. Flow %
7.47%
Top 10 Hldgs %
43.7%
Holding
66
New
21
Increased
14
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$8.07M
2
ALKS icon
Alkermes
ALKS
+$7.69M
3
AERI
Aerie Pharmaceuticals
AERI
+$5.99M
4
WVE icon
Wave Life Sciences
WVE
+$5.88M
5
TVTX icon
Travere Therapeutics
TVTX
+$4.6M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$12.4M
2
EXEL icon
Exelixis
EXEL
+$7.89M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.2M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$5.95M
5
SHPG
Shire pic
SHPG
+$3.42M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IFRX icon
51
InflaRx
IFRX
$335M
$1.22M 0.45%
+32,500
New +$1.21M
GMED icon
52
Globus Medical
GMED
$11.1B
$1.2M 0.44%
24,200
– –
KYNB
53
Kyntra Bio
KYNB
$32.4M
$1.07M 0.4%
788
– –
TPST icon
54
Tempest Therapeutics
TPST
$17.9M
$925K 0.34%
+317
New +$701K
LGND icon
55
Ligand Pharmaceuticals
LGND
$5.67B
$918K 0.34%
11,702
-78,547
-87% -$5.95M
FOLD
56
DELISTED
Amicus Therapeutics
FOLD
$796K 0.29%
58,600
– –
MNTA
57
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$792K 0.29%
+54,580
New +$697K
TCDA
58
DELISTED
Tricida, Inc. Common Stock
TCDA
$751K 0.28%
+19,066
New +$444K
ARNA
59
DELISTED
Arena Pharmaceuticals Inc
ARNA
$740K 0.27%
+16,500
New +$757K
SGMO
60
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$457K 0.17%
48,000
– –
DERM
61
DELISTED
Dermira, Inc.
DERM
$407K 0.15%
+30,000
New +$250K
MGNX icon
62
MacroGenics
MGNX
$260M
$342K 0.13%
+19,000
New +$328K
FSTX
63
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
– –
-18,250
Closed -$596K
PTLA
64
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-24,000
Closed -$367K
ONCE
65
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-12,000
Closed -$369K
SHPG
66
DELISTED
Shire pic
SHPG
– –
-25,000
Closed -$3.42M
1 2
3

Similar funds

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
DT
Daniels + Tansey Wilmington, Delaware $289M AUM 18.06% 1-Year Est. Return
3LCM
3D/L Capital Management Hartford, Connecticut $308M AUM 13.67% 1-Year Est. Return
TFA
Triad Financial Advisors Greensboro, North Carolina $284M AUM 14.95% 1-Year Est. Return
SFG
Steward Financial Group Colleyville, Texas $315M AUM 13.78% 1-Year Est. Return
AEPLI
AH Equity Partners LSV I Menlo Park, California $315M AUM 9.31% 1-Year Est. Return
CC
Chanos & Company New York $318M AUM 4.62% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

International Biotechnology Trust's Q1 2019 Portfolio in Review

As of Q1 2019, International Biotechnology Trust held 66 positions worth $271M, up 68% from $161M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

International Biotechnology Trust deployed $20.2M of net new capital in Q1 2019, opening 21 new positions and adding to 14 existing holdings. Its largest new stake was PTC Therapeutics: 240,493 shares worth $9.05M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Incyte, an estimated $12.4M trimmed.

  • International Biotechnology Trust's largest Q1 2019 buy was PTC Therapeutics: 240,493 shares worth $9.05M.
  • International Biotechnology Trust added most to Aerie Pharmaceuticals in Q1 2019, an estimated $5.99M increase.
  • International Biotechnology Trust's biggest Q1 2019 reduction was Incyte, cutting an estimated $12.4M.
  • International Biotechnology Trust fully exited Shire pic in Q1 2019, selling an estimated $3.42M.
  • International Biotechnology Trust's ten largest holdings make up 44% of its $271M portfolio in Q1 2019.
  • International Biotechnology Trust opened 21 new positions and closed 4 in Q1 2019.
  • International Biotechnology Trust's portfolio value rose 68% quarter-over-quarter to $271M.

Based on International Biotechnology Trust's 13F filing for Q1 2019, filed 14 May 2019.